Single Dose Escalation First Time in Human PK Study

See also
Status	Clinical Trial	Phase
Completed	`NCT04079790` - Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects	Phase 1
Completed	`NCT01934205` - To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944	Phase 1
Not yet recruiting	`NCT02177721` - Clinical Benefit, Safety and PK of Raxibacumab in Subjects Exposed to Bacillus Anthracis	Phase 4
Suspended	`NCT01132417` - In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance	N/A
Completed	`NCT00539994` - Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus	Phase 2
Completed	`NCT01610388` - A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects	Phase 1
Completed	`NCT01262885` - A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects	Phase 1
Completed	`NCT00427141` - A Three-Part Study Of GSK580416 In Healthy Subjects	Phase 1
Completed	`NCT04620486` - Effect of BPA on Anchor Antibiotic Continuity in the ED: Randomized Controlled Trial	N/A
Recruiting	`NCT06451172` - Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis	Early Phase 1
Not yet recruiting	`NCT06440304` - Therapeutic Options for CRAB	Phase 4
Completed	`NCT02292498` - Thermal Imaging to Diagnose and Monitor Suspected Bacterial Infections	N/A
Completed	`NCT01587768` - WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics	N/A
Withdrawn	`NCT01039610` - A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.	Phase 1
Completed	`NCT00259909` - Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)	N/A
Completed	`NCT01431989` - Amoxicillin Bioequivalence Study Brazil - Fast	Phase 1
Completed	`NCT02778672` - Thermal Imaging of the Lung on a Smartphone to Differentiate Bacterial From Non Bacterial Causes of Pneumonia	N/A
Completed	`NCT00896558` - A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects	Phase 1
Completed	`NCT02045797` - Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections	Phase 2
Active, not recruiting	`NCT05752019` - TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era

NCT number	NCT00828867
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 1
Start date	November 14, 2008
Completion date	December 7, 2009

Single Dose Escalation First Time in Human PK Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms